France· FR:65839815
CYSTADROPS 3,8 mg/mL, collyre en solution
A medicinal product containing chlorhydrate de mercaptamine, registered in France by RECORDATI RARE DISEASES, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE MERCAPTAMINE
- Manufacturer
- RECORDATI RARE DISEASES
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009300815251 flacon(s) en verre jaune(brun) de 5 ml avec compte-gouttesEUR 1.1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCYSTADROPSRecordati Rare Diseases, Puteaux
- SwitzerlandCystadrops 3.8 mg/ml, AugentropfenRECORDATI AG
- FinlandCystadropsRecordati Rare Diseases
- IrelandCystadrops 3.8 mg/mL eye drops solutionRecordati Rare Diseases
- IcelandCYSTADROPSRecordati Rare Diseases*
- NetherlandsCystadrops 3,8 mg/ml oogdruppels, oplossingOrphan Europe SARL
- NorwayCystadropsRecordati Rare Diseases
- PolandCystadropsRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
- Norway · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a057f4eb-cae5-4457-9da7-0d8c3be1ce19 GET /v1/drugs/a057f4eb-cae5-4457-9da7-0d8c3be1ce19?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65839815",
"date_amm": "2017-01-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1049",
"substance": "CHLORHYDRATE DE MERCAPTAMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.